Trialbee Partners With LiveRamp
Trialbee has announced a partnership with LiveRamp, to expand the pool of potential patients and then match and engage patients for clinical trials in a privacy-centric way. Trialbee will leverage LiveRamp’s identity infrastructure and integration network to identify and reach potential clinical trial patients and remain engaged with those patients throughout their clinical trial journey.
Over 80% of regulated phase II-III clinical trials fail to meet planned enrollment targets and are delayed six or more months, jeopardizing data quality and development timelines. Inefficient and untargeted recruitment efforts for late-stage trials cause rise in direct operational development costs and lost revenues due to delayed time to market.
For more information, click here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
